Abstract:
Background: Chronic liver disease is the gradual distraction of liver tissue. The risk factors for
Chronic liver disease may vary in different population. In Ethiopia the main causative agents of
chronic liver disease are hepatitis B and C viruses and alcohol. Hepatitis B virus (HBV) infected
patients with a positive Hepatitis B e- antigen (HBeAg) result indicates the presence of active
replication and high infectivity. Determining the prevalence of HBV infection and HBeAg
among CLD patients in each region is essential for managing the diseases and designing
healthcare strategies.
Objective: The aim of this study is to determine the prevalence of HBsAg, HBeAg, and
associated risk factors among patients with chronic and suspected liver disease in in Bahir Dar
Governmental Specialized Hospitals, Amhara National Regional State, North west Ethiopia.
Methods: A cross-sectional study design was conducted among 384 patients with chronic and
suspected liver disease who visited Governmental specialized hospitals from June to August
2024. Socio-demographic and associated risk factor data were collected using a structured
questionnaire. Five ml of blood sample was collected from each study participant. ELISA and
Maglumi HBeAg kits were used to detect HBsAg and HBeAg respectively. The results were
analyzed using SPSS version 27.
Results: The total prevalence of HBsAg was 34.9 %( 134/384; 95% CI; 30.1-39.9), among CLD,
and in suspected liver disease patients were 50.5% (95/188) and 19.9% (39/196), respectively.
The overall prevalence HBeAg was 35.1% (47/134; 95% CL; 27.0-43.8). The prevalence of
HBeAg among chronic and suspected liver disease patients was 37.9% (36/95) and 28.2%
(11/39), respectively. High prevalence of HBsAg and HBeAg was found among male and
frequent alcohol user study participants. History of hospital admission (AOR=2.736 (95%
CI=1.66-4.50)) and contact with jaundiced patients (AOR=2.3 (95% CI=1.36-3.81)) had a
statistically significant association with HBV infection.
Conclusion: Half of CLD patients were infected with HBV. More than 30% of them were
positive for HBeAg. HBsAg and HBeAg were high among males with a history of hospital
admission and contact with jaundice patients. We recommended chronic HBV-infected and
suspected liver disease patients should be screened for HBeAg, and early management of the
diseases is mandatory to prevent liver cancer and transmission of HBV infection.